|
Trace One Regulatory Compliance
Posted By:
Sandhya Sashikumar
Summary
The FDA's 2026 Human Foods Program agenda introduces significant regulatory developments affecting food ingredient safety, labeling, and traceability. A key proposal is GRAS reform, which would require mandatory FDA notification for substances considered Generally Recognized as Safe. Comments close December 9, 2026, while major compliance deadlines include February 25, 2028, for the "Healthy" claim rule and July 20, 2028, for FSMA 204 food traceability requirements. Not all initiatives are currently enforceable, but food manufacturers should begin reviewing ingredient safety documentation, labeling practices, and supplier records now to identify compliance gaps and prepare for upcoming requirements.
FDA's 2026 Human Foods Program (HFP) agenda covers food chemical safety, nutrition and labeling, microbiological safety, and traceability, and the item most likely to change daily work for regulatory and ingredient teams is the proposed GRAS reform rule, which would require a formal notification to FDA before a Generally Recognized as Safe (GRAS) substance can be marketed in human or animal food. Most 2026 activity is comment and preparation, with the compliance dates that carry real consequences arriving in 2028 and after.
What is the FDA Human Foods Program 2026 agenda?
The FDA Human Foods Program 2026 agenda is FDA's statement of regulatory and enforcement priorities for human food. It combines existing requirements, proposed rules, guidance, scientific assessments, and enforcement priorities, and the legally binding obligations for any company come from the specific FDA regulations that apply to its product, its activity, and its place in the supply chain. Manufacturers therefore need to sort each item by whether it is legally effective today or still being proposed or developed.
Who needs to pay attention?
The requirements apply primarily to U.S. and foreign companies that manufacture, process, pack, hold, import, or sell human food and dietary supplements for the U.S. market. FDA's particular focus areas include food ingredients and chemicals, dietary supplements, infant foods, produce, seafood, dairy and eggs, and foods covered by the Food Traceability Rule, with obligations that vary by product and supply-chain role.
What's new in 2026: key dates
- FDA Food Code: On 17th September, 2025 FDA Published Food Code 2026 which provides model food safety standards for retail food establishments and food service operations, guiding state and local authorities on safe food handling, sanitation, storage, and preparation practices.
- Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods: On 13th October Federal register published a final rule to amend its standards of identity (SOI) regulations, permitting the use of safe and suitable salt substitutes in standardized foods to reduce sodium content. This regulatory change aims to support a healthier food supply and reduce the risk of diet-related chronic diseases, such as hypertension, heart disease, and stroke.
- FDA Permits the safe use of vitamin D₂ inactive baker's yeast as a source of vitamin D: On 25th September an amendment to 21 CFR § 172.383 was established to ensure any use of vitamin D₂ inactive baker’s yeast complies with FDA-authorized food categories, conditions of use, and applicable labeling requirements.
- GRAS reform (proposed rule): FDA issued an update on August 10, 2026, and comments close December 9, 2026. If finalized, the rule would amend 21 CFR parts 170 and 570 to require submission of GRAS notices for the use of a human or animal food substance purported to be GRAS under section 201(s) of the FD&C Act (21 U.S.C. 321(s)).
- Post-market chemical safety assessment: FDA finalized the framework on May 12, 2026, and it is already active through reviews of butylated hydroxytoluene (BHT) and azodicarbonamide (ADA).
- "Healthy" claim: FDA's updated final rule establishes new criteria for foods labeled as "healthy," requiring products to contain specified amounts of recommended food groups, such as fruits, vegetables, whole grains, dairy, or protein foods, while meeting limits for added sugars, saturated fat, and sodium. Manufacturers using the claim must review product formulations, nutritional profiles, and labeling to ensure compliance by February 25, 2028.
- Food Traceability Rule (FSMA 204): FDA's Food Traceability Rule introduces additional recordkeeping requirements for manufacturers, processors, packers, and handlers of foods on the Food Traceability List, including certain fresh produce, seafood, and cheeses. Businesses must maintain Key Data Elements (KDEs) for Critical Tracking Events (CTEs), such as receiving, shipping, and transformation, to improve traceability and accelerate responses to food safety incidents. FDA enforcement is deferred until July 20, 2028, giving companies additional time to strengthen supplier coordination, traceability systems, and recordkeeping processes.
- Front-of-package labeling: FDA's proposed rule would require most packaged foods bearing a Nutrition Facts label to display a standardized Nutrition Info box on the front of the package, identifying whether saturated fat, sodium, and added sugars are present at low, medium, or high levels. FDA has targeted December 2026 for finalization, although the rule remains proposed. If finalized as drafted, manufacturers with $10 million or more in annual food sales would have three years after the rule's effective date to comply, while smaller businesses would have four years. Manufacturers should begin assessing potential impacts on packaging, nutritional data, and label design.
What is GRAS reform, and why does it matter?
GRAS reform is the proposed change that would turn GRAS notification to FDA into a requirement. For ingredient and regulatory teams, the practical consequence is that the safety documentation behind every ingredient a company treats as GRAS may need to withstand FDA review, and that documentation has to exist and be organized before a final rule sets a deadline.
"GRAS reform raises the bar for how companies demonstrate safety. The question is no longer simply whether an ingredient is considered GRAS, but whether the underlying scientific evidence and regulatory rationale are sufficiently robust to withstand FDA scrutiny." Sandhya Sashikumar, Senior Regulatory Compliance Specialist, Trace One
The comment period is also the last opportunity to influence the scope of the rule, which makes a GRAS ingredient inventory worth starting now.
What are companies getting wrong about the Human Foods Program?
Two opposite habits cause trouble: some teams treat HFP initiatives as preliminary and wait for final rules before acting, while others assume every announced initiative applies immediately, when the 2026 agenda actually blends existing requirements with proposals, guidance, and policy work still taking shape.
A more useful measure of readiness is whether a company can demonstrate the safety, compliance, traceability, and scientific basis of its products when FDA asks. That depends on knowing where the company's regulatory vulnerabilities sit and addressing them ahead of the question.
What happens if a company does nothing?
Non-compliance may be treated as a violation, depending on the product and the severity, with elevated risk of import refusals and warning letters. Companies with unaddressed gaps also tend to be first in line for post-market scrutiny, followed by reformulation or recall pressure.
What changes in day-to-day compliance work?
Teams may need to strengthen documentation and record keeping, reassess the safety substantiation behind ingredients and chemicals, review labeling and claims, verify traceability and supplier controls, and keep food-safety procedures inspection-ready. Some products and obligations will also call for additional testing, updated risk assessments, or revised internal timelines, and those requirements vary by company, so each needs to be assessed against the specific FDA rules covering the business.
The biggest operational shift is toward proactive work, since FDA is emphasizing inspections, imported-food oversight, traceability, food-chemical reviews, and more systematic risk management. Each initiative creates a different exposure:
- GRAS reform: gaps in safety documentation
- "Healthy" and front-of-package labeling: label and claims review
- FSMA 204: recordkeeping gaps across the supply chain
- Post-market chemical assessment: exposure for any additive FDA reassesses, starting with BHT and ADA
Who inside the company feels it first?
Regulatory Affairs and R&D or ingredient sourcing feel it first, since they own the safety substantiation and formulation records. Quality Assurance follows for document retention and audit-readiness, legal and trade compliance take on import certification exposure next, and marketing and labeling teams generally come in at a later stage.
How to prepare: a six-step roadmap
- Build a GRAS ingredient inventory now, before a final rule sets a deadline.
- Sort each HFP initiative into three groups: effective today, proposed, and in development.
- Review the safety substantiation and scientific rationale behind each ingredient you rely on.
- Check labels and claims against the "Healthy" and front-of-package timelines.
- Test traceability records and supplier controls against FSMA 204.
- Map each regulatory change to the formulas, labels, markets, and suppliers it affects.
Where does Trace One fit?
Most of the effort in regulatory work goes into working out how a specific change affects an actual product or ingredient, which means connecting the rule to formulas, labels, markets, and suppliers. Trace One identifies regulatory changes early and links them to the products, ingredients, suppliers, and labels that may be affected, so Regulatory, Quality, and R&D teams can find compliance gaps and act before the change becomes a business problem. That reduces the cost of last-minute work such as reformulating, reprinting labels, or delaying a launch.
One global food manufacturer facing increasingly complex requirements across multiple markets had relied on manual research and a mix of sources. After centralizing its regulatory information in Trace One, the team could monitor changes and assess requirements more efficiently. Much of a regulatory team's time goes into checking ingredient requirements, labeling rules, and country-specific limits alongside reading the regulation itself, and that day-to-day checking is where a platform makes the most difference.
The documentation behind each ingredient takes time to build, and the timeline for the final rule is not in a company's control.
Frequently Asked Questions
